TABLE 1.
Characteristics of patients in the present study
| Patients n = 20 | |
|---|---|
| Age, y | |
| Mean ± SD | 48.9 ± 10.9 |
| Median (minimum–maximum) | 48.0 (24–72) |
| Sex | |
| Male | 14 (70.0%) |
| Female | 6 (30.0%) |
| Type of pemphigus | |
| PV | 11 (55.0%) |
| PF | 8 (40.0%) |
| PV/PF overlap | 1 (5.0%) |
| Severity of disease (PDAI score) | |
| Mean ± SD | 11.7 ± 7.7 |
| Median (minimum–maximum) | 10.5 (2–27) |
| Serum anti‐Dsg antibody | |
| Dsg1 (n = 18) | |
| Mean ± SD | 343.34 ± 327.16 |
| Median (minimum–maximum) | 276.00 (27.7–1300.0) |
| Dsg3 (n = 10) | |
| Mean ± SD | 513.54 ± 366.51 |
| Median (minimum–maximum) | 499.00 (40.1–973.0) |
| Concomitant therapy | |
| Yes | 17 (85.0%) |
| No | 3 (15.0%) |
Abbreviations: Dsg1, desmoglein 1; Dsg3, desmoglein 3; PDAI, pemphigus disease area index; PF, pemphigus foliaceus; PV, pemphigus vulgaris; SD, standard deviation.